Alkermes plc Releases Strong Second Quarter Financial Results for 2025 Alkermes plc announces solid financial results for the second quarter of 2025, highlighting strong revenues and positive developments in product performance.

Alkermes plc Releases Strong Second Quarter Financial Results for 2025 #Ireland #Dublin #Alkermes #VIVITROL #ARISTADA

Alkermes Presents Research on Mental Health Drugs at Major Conferences in Spring 2025 Alkermes showcased its latest findings related to mental health medications at prominent conferences during Spring 2025, spotlighting important data on LYBALVI and ARISTADA.

Alkermes Presents Research on Mental Health Drugs at Major Conferences in Spring 2025 #Ireland #Dublin #Alkermes #LYBALVI #ARISTADA